Skip to the content
Pictorlogo darklogo light
  • Human Health
    • SARS-CoV-2 Antibodies
  • Animal Health
    • Johne’s Disease / MAP
    • Mycoplasma bovis
  • Technology
    • Multiplex Solution
    • eIFUs & Downloads
  • About
    • About Pictor
    • Our People
    • Our Board
  • News
  • Contact Us
  • Investors
Pictor
  • Human Health
    • SARS-CoV-2 Antibodies
  • Animal Health
    • Johne’s Disease / MAP
    • Mycoplasma bovis
  • Technology
    • Multiplex Solution
    • eIFUs & Downloads
  • About
    • About Pictor
    • Our People
    • Our Board
  • News
  • Contact Us
  • Investors
Pictor
  • Human Health
    • SARS-CoV-2 Antibodies
  • Animal Health
    • Johne’s Disease / MAP
    • Mycoplasma bovis
  • Technology
    • Multiplex Solution
    • eIFUs & Downloads
  • About
    • About Pictor
    • Our People
    • Our Board
  • News
  • Contact Us
  • Investors
29 September 2021
Technology

Pictor and SCIENION partner to commercialise high-throughput SARS-CoV-2 antibody testing system to support ongoing fight against pandemic

Categories
  • Animal Health (2)
  • Human Health (4)
  • PRESS RELEASE (5)
  • Technology (1)
Tags

Awanui Group Bovine Clinical Trials CoVID-19 Dairy Investment k1w1 K One W One MAP Marko Bogoievski Massey University Mobility Health MPI PRESS RELEASE SARS-CoV-2 Scienion SFFF Sir Stephen Tindall Tasso

Head Office
Pictor Ltd.

24 Balfour Road, Parnell, Auckland 1052, New Zealand


NZ +64 9 3090950

info@pictordx.com

Pictor products are manufactured in ISO 13485:2016 certified facilities.

  • Linkedin
  • Facebook
  • Twitter
  • Instagram

© 2022 Pictor Limited, All Rights Reserved.

Site by Memory Partners

Back to top
Drag